Advertisement
Skip to Content

Boston Scientific Corp BSX Stock Quote

| Rating as of

NYSE: BSX

Last close prices updated as of Feb 06, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 47.66
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Large Growth
  • Day Range 47.55  –  48.23
  • Year Range 34.98  –  48.23
  • Market Cap 68.2640 Bil
  • Volume / Avg 6.0 Mil /  6.3 Mil
  • Price / Sales 5.41
  • Price / Book 3.87
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis BSX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Boston Scientific Ends 2022 in Strong Fashion; No Change to Our Fair Value Estimate

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie Wang |

Narrow-moat Boston Scientific reported solid full-year top-line results that were consistent with our expectations, but reported earnings fell well short of our projections thanks to an unanticipated reserve to accommodate any efforts by the Italian government to claw back some of its healthcare spending. However, after adjusting for this event, full-year earnings per share nearly hit our estimate on the nose. At this point, we’re leaving our fair value estimate intact, as we saw little in the quarter to change our longer-term projections for Boston, and our 2023 estimates remain bound by management’s outlook.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BSX

Company Profile BSX

Business Description

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Contact
300 Boston Scientific Way
Marlborough, MA, 01752-1234
Industry Medical Devices
Employees 41,000

Related Articles BSX

FAQs for Boston Scientific Corp Stock

No. BSX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BSX’s market cap is 68.26 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BSX’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BSX’s price/sales is 5.51.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

BSX’s price/forward earnings is 25.38.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

BSX’s price/book is 3.87.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See BSX’s valuation ratios compared to the Market Index.

BSX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BSX’s historical performance against its industry peers and the overall market.